Zhitong Finance App News, Mei Nian Health (002044.SZ) issued an announcement. According to the company's business needs, it intends to sign a “Framework Cooperation Agreement” with Mega Genomics Limited (06667.HK, hereinafter referred to as “MineGene”). The company and its subsidiaries and MineGene and its related entities carry out business cooperation on testing services, testing and related supporting products required for the service during the validity period of the agreement. The two parties may increase, adjust or adopt written means by consensus according to market requirements, business development, regulatory policies and the business conditions of the two parties Cancelling specific cooperation projects.
The company plans to sign a “Framework Cooperation Agreement” with Maingene for daily business needs, which is conducive to leveraging the business synergy between the two sides, stabilizing the supply of testing services and consumables, in line with the company's development strategy, and helping to enhance the company's core competitiveness and enhance profitability and sustainable development capabilities. The transaction price is determined fairly and reasonably according to the market price. There is no harm to the interests of the company and its shareholders, especially small and medium shareholders. It will not affect the company's independence, nor will it become dependent on related parties. It is not expected to have a significant adverse impact on the company's current and future financial conditions and operating results.